Evidence map›Paper›PMID 41726280›Full record

ArticleIndustrial psychiatry journal

Perspectives of opioid users on overdose recognition, naloxone administration, and attitudes.

Rajnish Raj, Shaheena Parveen, Sajid Mohammad Wani, Zaid Ahmad Wani, Yasir Hassan Rather, Inaamul Haq

Abstract read
In one paragraph

Article in Industrial psychiatry journal. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Rajnish RajDepartment of Psychiatry, Institute of Mental Health and Neurosciences Kashmir, Government Medical College, Srinagar, Jammu and Kashmir, India.
Shaheena ParveenDepartment of Psychiatry, Institute of Mental Health and Neurosciences Kashmir, Government Medical College, Srinagar, Jammu and Kashmir, India.
Sajid Mohammad WaniDepartment of Psychiatry, Institute of Mental Health and Neurosciences Kashmir, Government Medical College, Srinagar, Jammu and Kashmir, India.
Zaid Ahmad WaniDepartment of Psychiatry, Institute of Mental Health and Neurosciences Kashmir, Government Medical College, Srinagar, Jammu and Kashmir, India.
Yasir Hassan RatherDepartment of Psychiatry, Institute of Mental Health and Neurosciences Kashmir, Government Medical College, Srinagar, Jammu and Kashmir, India.
Inaamul HaqDepartment of Community Medicine, Government Medical College, Srinagar, Jammu and Kashmir, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: There has been a rise in opioid overdose deaths, despite harm reduction efforts like naloxone distribution. Naloxone is effective but underused due to knowledge gaps and stigma. Aim: To assess opioid users' knowledge regarding overdose and attitudes, experiences toward naloxone. Materials and Methods: This cross-sectional study was conducted from August 2024 to May 2025 at a Deaddiction center. Participants with opioid use disorder were interviewed using a semistructured performa and the Brief Opioid Overdose Knowledge questionnaire to assess opioid users' knowledge and attitudes toward naloxone. Results: Our study involved 501 participants, mostly males (mean age = 27.16 years) with substance use averaging 6.5 years. Nearly half had overdose history, with serious outcomes common. Knowledge, overdose recognition, and overdose response scores varied significantly based on factors like history of overdose, awareness and use of naloxone, education, and socioeconomic status. Knowledge about naloxone was low, with mixed attitudes and significant barriers like stigma and poor access. Conclusion: Our study reveals that despite naloxone's proven efficacy in reversing opioid overdoses, its use is limited by stigma, poor awareness, and restricted access. Enhancing harm reduction education and destigmatization through tailored community interventions is vital to preventing overdose fatalities.

Indexed as

BuprenorphineKashmir naloxonenaloxonenaloxone stigmaoverdose knowledge

Identifiers

PMID41726280
PMCPMC12923245

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.